ライフサイエンスコーパス: infectious mononucleosis

1 V infection, defined as flu-like symptoms or infectious mononucleosis).

2 oratory utilization, and office diagnosis of infectious mononucleosis.

3 nonspecific symptoms, or have self-limiting infectious mononucleosis.

4 cells can limit EBV replication and prevent infectious mononucleosis.

5 nited Kingdom are seen only in patients with infectious mononucleosis.

6 orrelates with the incidence and severity of infectious mononucleosis.

7 nical and virologic evaluations during acute infectious mononucleosis.

8 disease was reported in patients with acute infectious mononucleosis.

9 namics of CD4(+) and CD8(+) T cells in acute infectious mononucleosis.

10 al treatment of uncomplicated or complicated infectious mononucleosis.

11 the subsequent establishment of latency and infectious mononucleosis.

12 less IL-18 and Mig protein than tissues with infectious mononucleosis.

13 Of these, 77% had infectious mononucleosis, 12% had atypical symptoms, and

14 p for effect size=1.5 x 10(-19); I(2)=43%), infectious mononucleosis (2.17, 1.97-2.39; p=3.1 x 10(-5

15 of HD not associated with HIV (28%, 33%) and infectious mononucleosis (33%).

16 ein-Barr virus (EBV), the causative agent of infectious mononucleosis, a self-limiting lymphoprolifer

17 plex phenotype manifested by severe or fatal infectious mononucleosis, acquired hypogammaglobulinemia

18 clear cells from Chinese children with acute infectious mononucleosis (AIM) and chronic active EBV in

19 blood of 10 individuals followed from acute infectious mononucleosis (AIM) into convalescence (CONV)

20 m cancer specimens was not observed in acute infectious mononucleosis (AIM) patients.

21 ls experiencing primary EBV infection (acute infectious mononucleosis [AIM]) and again 6 months later

22 h acute symptomatic primary infection (acute infectious mononucleosis [AIM]).

23 ells for at least a year after resolution of infectious mononucleosis, although the clone size is red

24 ) was present in 66% of patients (12/20 with infectious mononucleosis and 12/16 with tonsillar hyperp

25 samples from 20 American children with acute infectious mononucleosis and 16 Swiss children with chro

26 Though it is associated with infectious mononucleosis and approximately 200,000 cance

27 Epstein-Barr virus (EBV) causes infectious mononucleosis and can lead to lymphoprolifera

28 s both acute infections that result in acute infectious mononucleosis and chronic infections that res

29 are associated with prolonged fatigue after infectious mononucleosis and contrast these factors with

30 readily detected at presentation with acute infectious mononucleosis and declined rapidly thereafter

31 Epstein-Barr virus is the causative agent of infectious mononucleosis and infects approximately 90% o

32 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with cancers

33 EBV causes infectious mononucleosis and is associated with certain

34 human herpesvirus, is the causative agent of infectious mononucleosis and is associated with many car

35 The ubiquitous EBV causes infectious mononucleosis and is associated with several

36 rus (EBV) is a human herpesvirus that causes infectious mononucleosis and is associated with several

37 n-Barr virus (EBV) is the causative agent of infectious mononucleosis and is associated with several

38 Barr virus (EBV) is the most common cause of infectious mononucleosis and is associated with the deve

39 s a ubiquitous human herpesvirus that causes infectious mononucleosis and is etiologically associated

40 by T cell surveillance, nevertheless causes infectious mononucleosis and is strongly linked to sever

41 s (EBV) poses numerous health risks, such as infectious mononucleosis and lymphoproliferative disorde

42 arr virus is a human herpesvirus that causes infectious mononucleosis and lymphoproliferative maligna

43 mmaherpesvirus EBV, which is associated with infectious mononucleosis and malignant tumors, harbors m

44 milar between adolescents with CFS following infectious mononucleosis and recovered controls.

45 is a ubiquitous herpesvirus associated with infectious mononucleosis and several tumors.

46 hat LMP-1-del variants are frequent in acute infectious mononucleosis and tonsillar hyperplasia and i

47 e healthy donors with acute gastroenteritis, infectious mononucleosis, and Epstein-Barr virus/cytomeg

48 st that an EBV vaccine might help to prevent infectious mononucleosis, and further development of thi

49 A history of infectious mononucleosis, and high baseline EBV antibody

50 (EBV) infection is the most common cause of infectious mononucleosis, and persistent infection is as

51 n-Barr virus (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking showed the stronge

52 oid tissues diagnosed with acute EBV-induced infectious mononucleosis, as assessed by semiquantitativ

53 r disease manifestations include fatal acute infectious mononucleosis, B-cell lymphoma, and progressi

54 ated Lyme disease who were misdiagnosed with infectious mononucleosis based on false-positive tests f

55 onstituted up to 5% of the CD8(+) T cells in infectious mononucleosis blood, the strongest latent Ag-

56 Early, accurate diagnosis of infectious mononucleosis can help clinicians target trea

57 Infectious mononucleosis caused by Epstein-Barr virus (E

58 S in lymphoid tissues with acute EBV-induced infectious mononucleosis compared to tissues with PTLD a

59 f a healthy 19-year-old female who developed infectious mononucleosis complicated by unilateral empye

60 CFS from adolescents who have recovered from infectious mononucleosis (controls), while certain cytok

61 virus-host interactions during self-limited infectious mononucleosis could explain how Epstein-Barr

62 When fulminant infectious mononucleosis (FIM) was excluded, there was n

63 e, affected patients often develop fulminant infectious mononucleosis (FIM), a life-threatening condi

64 haracterize its clinical presentation: fatal infectious mononucleosis (FIM), lymphomas, and immunoglo

65 en results in the clinical syndrome of acute infectious mononucleosis (glandular fever).

66 atal, clinical sequelae, including fulminant infectious mononucleosis, hemophagocytic lymphohistiocyt

67 suggests a substantial genetic component in infectious mononucleosis (IM) etiology.

68 Infectious mononucleosis (IM) is an immunopathological d

69 Acute infectious mononucleosis (IM) is associated with altered

70 Infrequently, EBV infection causes infectious mononucleosis (IM) or Burkitt lymphoma (BL).

71 table in the nonswitched memory pool both in infectious mononucleosis (IM) patients undergoing primar

72 red with those found in healthy individuals, infectious mononucleosis (IM) patients, and 12 PTLD pati

73 cell responses that, by T cell cloning from infectious mononucleosis (IM) patients, appear skewed to

74 l sequences has suggested that patients with infectious mononucleosis (IM) who are undergoing primary

75 Analysis of infectious mononucleosis (IM), a clinical syndrome that

76 f Epstein-Barr virus (EBV) and occurrence of infectious mononucleosis (IM), a cross-sectional study w

77 ein-Barr virus (EBV), the causative agent of infectious mononucleosis (IM), a disease associated with

78 rast, infection later in life often leads to infectious mononucleosis (IM), a febrile illness charact

79 omatic, delayed infection is associated with infectious mononucleosis (IM), a febrile illness in whic

80 ary infection in adolescence can manifest as infectious mononucleosis (IM), as a fatal illness that m

81 + T cells is pathognomonic of EBV-associated infectious mononucleosis (IM), common in young adults.

82 In lymphoid tissues from patients with acute infectious mononucleosis (IM), interfollicular immunobla

83 his syndrome, which seems identical to human infectious mononucleosis (IM), persists for a further mo

84 to EBV, and induces a syndrome comparable to infectious mononucleosis (IM).

85 ng acute Epstein-Barr virus (EBV)-associated infectious mononucleosis (IM).

86 in the peripheral blood of 13 subjects with infectious mononucleosis (IM).

87 onuclear cells (PBMCs) from 26 patients with infectious mononucleosis (IM).

88 Controls included 8 cases of uncomplicated infectious mononucleosis (IM).

89 This consisted of the clinical syndrome of infectious mononucleosis in 7 children; in addition, 10

90 We present a paediatric case of infectious mononucleosis in a 13-year old, manifesting w

91 d, analogous in many respects to EBV-induced infectious mononucleosis in humans.

92 d normal activities support the concept that infectious mononucleosis is most likely acquired by kiss

93 Infectious mononucleosis is the clinical manifestation o

94 ein-Barr virus (EBV), the causative agent of infectious mononucleosis, is a human herpesvirus associa

95 Development of an infectious mononucleosis-like syndrome correlates with t

96 ishment of latency or the development of the infectious mononucleosis-like syndrome in infected mice.

97 ent, and both groups developed the prominent infectious mononucleosis-like syndrome that is character

98 Like EBV-infected humans with infectious mononucleosis, mice infected with the rodent

99 rus DNA in serum or plasma has been found in infectious mononucleosis, nasopharyngeal carcinoma, post

100 Factors involved in determining whether infectious mononucleosis occurs after primary EBV infect

101 These focus on: (i) patients with infectious mononucleosis or its fatal equivalent, X-link

102 d a cohort of 250 primary-care patients with infectious mononucleosis or ordinary upper-respiratory-t

103 pheral blood B cells, isolated from the same infectious mononucleosis patients, to determine whether

104 BV) is a human lymphocryptovirus that causes infectious mononucleosis, persists asymptomatically for

105 pidemiology that indicates that a history of infectious mononucleosis predisposes to HL.

106 68 causes a persistent infection, along with infectious mononucleosis, providing a model for studying

107 Three presented with EBV infectious mononucleosis requiring hospitalization, 1 ha

108 ells, obtained from donors with a history of infectious mononucleosis, showed diminished survival in

109 ped EBV primary infections, including 2 with infectious mononucleosis syndrome.

110 met the criteria for CFS 6 months following infectious mononucleosis; the figure was 7% at 12 months

111 eukoplakia to nasopharyngeal carcinoma, from infectious mononucleosis to Hodgkin's disease (HD) and B

112 humans range from the fairly benign disease infectious mononucleosis to life-threatening cancer.

113 es ranging from asymptomatic viremia through infectious mononucleosis to posttransplant lymphoprolife

114 A history of infectious mononucleosis was negatively associated with

115 nce and veteran-reported physician-diagnosed infectious mononucleosis were associated with CMI among

116 revealed that the majority of patients with infectious mononucleosis were infected with multiple str

117 Unlike acute infectious mononucleosis, wherein EBV establishes lifelo